Cas:160707-69-7 Apricitabine manufacturer & supplier

Chemical Name:Apricitabine

CAS.NO:160707-69-7

Synonyms:4-amino-1-[(2R,4R)-2-(hydroxymethyl)-1,3-oxathiolan-4-yl]pyrimidin-2(1H)-one;SPD754;AVX754;4-Amino-1-[(2R,4R)-2-(hydroxymethyl)-1,3-oxathiolan-4-yl]-2(1H)-pyrimidinone;2(1H)-Pyrimidinone, 4-amino-1-[(2R,4R)-2-(hydroxymethyl)-1,3-oxathiolan-4-yl]-;Apricitabine

Molecular Formula:C₈H₁₁N₃O₃S

Molecular Weight:229.256

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:475.4±55.0 °C at 760 mmHg

Density:1.7±0.1 g/cm3

Index of Refraction:1.755

PSA:115.67000

Exact Mass:229.052109

LogP:-1.35

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-amino-1-[(2R,4R)-2-(hydroxymethyl)-1,3-oxathiolan-4-yl]pyrimidin-2(1H)-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Apricitabine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,SPD754 Use and application,4-Amino-1-[(2R,4R)-2-(hydroxymethyl)-1,3-oxathiolan-4-yl]-2(1H)-pyrimidinone technical grade,usp/ep/jp grade.

Related News: The researchers found that compared with those with cancer, the prevalence of FT was higher among those with ASCVD (54 versus 41 percent). In adjusted analyses, when studying individual components of FT, those with ASCVD had increased odds of any difficulty paying medical bills, inability to pay bills, cost-related medication nonadherence, food insecurity, and foregone/delayed care due to cost (odds ratios, 1.22, 1.25, 1.28, 1.39, and 1.17, respectively). Apricitabine manufacturer The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses. Apricitabine supplier The FDA approval allows Biogen to sell its product over several years – with forecasts for potential annual sales reaching as high $10 billion to $50 billion – until the company completes a required follow-up study. Apricitabine vendor The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses. Apricitabine factory The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses.